Usefulness of KIT mutant transcript levels for monitoring measurable residual disease in t (8;21) acute myeloid leukemia

Documenti analoghi

• ZNF384 fusion transcript levels for measurable residual disease monitoring in adult B‐cell acute lymphoblastic leukemia
  di: Zong‐Yan Shi, et al.
  Pubblicazione: (2024)
• Clinical characteristics and prognosis of acute myeloid leukemia patients with Runt‐related transcription factor 1 mutation: A single‐center retrospective analysis
  di: Lin‐Ya Wang, et al.
  Pubblicazione: (2024)
• Secondary acute myeloid leukemia and early infection are independent predictors of poor survival in acute myeloid leukemia treated with hypomethylating agents and venetoclax
  di: Stefano Cordella, et al.
  Pubblicazione: (2024)
• FLT3‐ITD regulation of the endoplasmic reticulum functions in acute myeloid leukemia
  di: María Turos‐Cabal, et al.
  Pubblicazione: (2024)
• Isocitrate dehydrogenase 2 mutation promotes cytarabine resistance in acute myeloid leukemia by Warburg effect
  di: Jinrong Yang, et al.
  Pubblicazione: (2024)